September 30, 2020
Thomas Frinzi is the former Worldwide President, Surgical, Johnson & Johnson Vision business, which includes a broad ophthalmology portfolio across the areas of cataracts and refractive surgery (LASIK). Tom was appointed to his position in February 2017 at the conclusion of Johnson & Johnson’s acquisition of Abbott Medical Optics (AMO), a wholly-owned subsidiary of Abbott. Mr. Frinzi joined AMO in January 2016 as Senior Vice President of Abbott Laboratories and President, Abbott Medical Optics.
Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies. Most recently, he served as President and CEO of WaveTec Vision, a developer of surgical systems for eye surgery. He also held senior positions in commercial operations, business development, and sales and marketing at Bausch & Lomb Surgical, Refractec and Johnson & Johnson. In recognition of his leadership, expertise and vision in the field, Mr. Frinzi was awarded the 2015 Ophthalmology Innovation Award by the Ophthalmology Innovation Summit. He earned a bachelor’s degree in political science from the University of Tampa.
October 1, 2020
Dr. Link is a leader in the healthcare industry. He is a Managing Director of Versant Ventures, a leading venture capital firm focused in healthcare. At Versant, Bill has specialized in early-stage investing in medical devices. With more than two decades of operations experience in the healthcare industry, he has a proven record of building and managing large, successful medical product companies. Bill is also the Principal at Flying L Partners, the investment firm that funded SightLife’s creation of SightLife Surgical.
Prior to entering venture capital, Bill founded two companies which still today are leaders in the field of surgical ophthalmology. In 1987 Bill founded, and served as chairman and CEO of Chiron Vision, a subsidiary of Chiron Corporation specializing in ophthalmic surgical products. Prior to Chiron Vision, Bill founded and served as President of American Medical Optics, a division of American Hospital Supply Corporation.
Before entering the healthcare industry, Bill was an Assistant Professor in the Department of Surgery at the Indiana University School of Medicine. Bill received his B.S., M.S. and Ph.D. in Mechanical Engineering from Purdue University.
Richard P. Fox
October 1, 2020
Richard P. Fox (Rick) is an independent director of companies in diverse industries. He previously held executive, operational and financial positions at CyberSafe, Wall Data, and PACCAR and is the former managing partner of EY’s Seattle office. Early in his EY career, Rick served six years in the firm’s Sao Paulo, Brazil office.
Mr. Fox has been a member of the Board of Directors of HonorHealth since 2011 and is Chairman of the Honor Health Captive Insurance Exchange. He formerly served 17 years on the board of directors of Premera Blue Cross, a Northwest managed care company. He serves on the board of directors of Univar Inc., an international chemical distributor; LiveRamp Holdings, Inc., an identity platform solution company, FrontDoor Inc, a home services business, Pinnacle West Capital Company, an Arizona public utility and SightLife, a not for profit organization dedicated to elimination of corneal blindness worldwide. He served on the board of Shurgard Self Storage, an REIT until August 2006 when it was sold to Public Storage; aQuantive, an online marketing company, until it was sold to Microsoft in August 2007; and PopCap Games, a casual game company until it was sold to Electronic Arts in August 2011.
Fox is a 1969 graduate of Ohio University and a 2004 graduate of The Duke MBA—Global Executive MBA program with concentration in Health Sector Management. He is a CPA in Washington State. Mr. Fox is married and has two children and four grandchildren.
October 1, 2020
John Gebhart is a seasoned entrepreneurial leader who has worked in emerging health and technology companies for more than 30 years in the roles of CFO, COO, and CEO. His areas of specialization include financial and operations management, capital formation, strategic planning, financial modeling, organization development, and investor relations and has raised more than $150 million for his companies. Most recently he was CFO Acucela, Inc., a clinical stage ophthalmology developing diverse portfolio of drugs and devices to preserve and restore vision. He previously served as CFO for Qliance Medical Management Inc, a leader in direct primary care services, and CEO of Carewise Inc., a pioneer in telephone nurse triage and patient advocacy.. He has also he operated an independent consultancy providing project management and interim executive services to a variety of health services and technology companies including Remote Medical International, Ventripoint, PhysioSonics, Carena, Clarity Health, Nexcura, and DS-IQ. He began his career as a CPA with Ernst & Young and received his MBA from Pepperdine University in Malibu, CA.
October 1, 2020
Dr. Lindstrom is the founder and attending surgeon at Minnesota Eye Consultants, Adjunct Clinic Professor Emeritus at the University of Minnesota Department of Ophthalmology and visiting professor at the UC Irvine Gavin Herbert Eye Institute.
Dr. Lindstrom is a board-certified ophthalmologist and internationally recognized leader in corneal, cataract, refractive, glaucoma and laser surgery. He has been at the forefront of ophthalmology’s evolutionary changes throughout his career, as a recognized researcher, teacher, inventor, writer, lecturer and highly acclaimed physician and surgeon.
After graduating Magna Cum Laude from the College of Liberal Arts at the University of Minnesota, Dr. Lindstrom completed his doctorate degree in medicine in 1972. He has been awarded over 40 patents in ophthalmology and has developed a number of corneal preservation solutions, intraocular lenses and instruments that are used in clinical practices globally. He has co-edited seven books, published over 350 peer reviewed journals and 60 book chapters.
He is the recipient of numerous awards for distinguished service by national and international ophthalmology associations, including the LANS, Barraquer and the first lifetime achievement award from the International Society of Refractive Surgery.
Christine Z. McCauley
October 1, 2020
Christine Z. McCauley is Corporate Vice President, Global Human Resources, for Edwards Lifesciences. Christine has served in this role since 2012 and has over 30 years of experience working in all the functional disciplines of Human Resources. Christine leads the network of more than 300 global HR professionals who provide programs and services for approximately 13,000 Edwards’ employees in over 40 countries, of which more than 4,000 are located in Orange County.
Christine’s leadership is fueled by a passion for Edwards’ patient-focused mission and fostering an inclusive culture where all employees engage, grow, and thrive. Christine’s broad expertise in HR and leadership as well as her strategic mindset for developing and mobilizing talent have contributed to the success of the global corporate strategy since the inception of Edwards in 2000. Her authentic and caring leadership style is one she generously offers not only within Edwards but also in the community where she serves as a member on several boards.
Before joining Edwards Lifesciences in 1999, Christine held a variety of HR positions at Texas Instruments, Loral (Ford) Aerospace, and Bally’s Health and Tennis. She earned a dual bachelor’s degree in business administration and organizational effectiveness at The College at Brockport State University of New York and a master’s degree in human resource management from Chapman University.
September 30, 2020
Monty Montoya has earned global recognition for his persistent passion for eliminating corneal blindness worldwide by transforming how ophthalmologists care for the cornea. He is considered an innovative leader for working tirelessly for the past 20 years to bring sight-restoring transplants to the 10 million individuals waiting in darkness around the globe.
In October 2016, Monty became the CEO of CorneaGen (formerly SightLife Surgical), a mission-driven company seeking innovation and improvements in all dimensions of cornea care. Through partnerships, investments and education, Monty and his team drive research and development of scalable therapeutics for the prevention and treatment of corneal disease. He leads CorneaGen in supporting ophthalmologists and their patients with a spectrum of services, including the latest products and devices, delivery of the highest-quality tissue, surgeon education and advocacy for patient access to care and reimbursement policies.
Prior to taking the helm of CorneaGen, Monty was the CEO of SightLife, and guided its growth from annual revenues of $800,000 to over $40 million while driving positive change in cornea care space. SightLife’s success and impact under Monty’s leadership garnered many accolades, including Northwest EY Life Science Entrepreneur of the Year in 2014 and several Best Places to Work recognitions over the past 15 years.
In 2009, Monty was honored with the Eye Bank Association of America’s coveted Heise Award—an award given to a non-medical individual who has made the greatest contribution to advancing the cause of eye banking. He holds a bachelor’s degree from Arizona State University and an MBA from Duke University.